genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 4.900
-0.480 (-8.92%)
Last updated: Nov 3, 2026, 4:45 PM CET
genXone Revenue
genXone had revenue of 566.92K PLN in the quarter ending June 30, 2026, with 15.65% growth. This brings the company's total for the last twelve months to 2.48M, up 24.19% year-over-year. In the year 2025, genXone had annual revenue of 2.34M with 31.07% growth. That makes genXone the 44,276th largest company in the world by revenue and 495th in Poland.
Revenue (ttm)
2.48M
Revenue Growth
+24.19%
P/S Ratio
7.16
Revenue / Employee
n/a
Employees
17
Market Cap
16.19M
Revenue by Geography
- Poland 1.73M 73.9%
- Unallocated 426.93K 18.2%
- Outside Poland 184.40K 7.9%
Fiscal year ended Dec 31, 2025 See the full genXone breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.34M | 555.51K | 31.07% |
| Dec 31, 2024 | 1.79M | -606.63K | -25.33% |
| Dec 31, 2023 | 2.39M | -8.19M | -77.38% |
| Dec 31, 2022 | 10.59M | -12.61M | -54.36% |
| Dec 31, 2021 | 23.20M | 2.72M | 13.29% |
| Dec 31, 2020 | 20.47M | 20.27M | 9,907.43% |
| Dec 31, 2019 | 204.59K | 147.86K | 260.66% |
| Dec 31, 2018 | 56.73K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 257.23M |
| Synthaverse | 48.76M |
| Mabion | 17.61M |
| Read-Gene | 16.66M |
| Molecure | 6.52M |
| Urteste | 2.77M |
| NanoGroup | 2.37M |
| Captor Therapeutics Spolka Akcyjna | 2.01M |